Appeals court overturns patent board in Bard spat with AngioDynamics

Appeals court overturns patent board in Bard spat with AngioDynamics

Source: 
Mass Device
snippet: 

A federal court this week reversed a number of Patent Trial and Appeal Board rulings which invalidated patents held by Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard in an ongoing patent spat with AngioDynamics (NSDQ:ANGO) .